英文名称 | a2b1Integrin Recognition Sequence |
---|---|
中文名称 | N/A |
CAS号 | 134580-64-6 |
分子式 | C14H22N4O9 |
分子量 | 390.35 |
外观 | No Data Available |
熔点 | No Data Available |
沸点 | 955.2±65.0 °C | Condition: Press: 760 Torr |
酸度系数pKa | 3.36±0.10 | Condition: Most Acidic Temp: 25 °C |
英文名称 | a2b1Integrin Recognition Sequence |
---|---|
中文名称 | N/A |
CAS号 | 134580-64-6 |
分子式 | C14H22N4O9 |
分子量 | 390.35 |
外观 | No Data Available |
熔点 | No Data Available |
沸点 | 955.2±65.0 °C | Condition: Press: 760 Torr |
酸度系数pKa | 3.36±0.10 | Condition: Most Acidic Temp: 25 °C |
WKQ-0073078
英文名称:a2b1Integrin Recognition Sequence
英文别名:L-Alanine, N-[N-(N-L-α-aspartylglycyl)-L-α-glutamyl]-;L-α-Aspartylglycyl-L-α-glutamyl-L-alanine;1011: PN: US20090175821 SEQID: 1278 claimed protein;107: PN: US20100136614 SEQID: 108 unclaimed sequence;10: PN: US20110293666 SEQID: 10 unclaimed sequence;10: PN: WO2010054316 SEQID: 10 unclaimed sequence;10: PN: WO2016163828 PAGE: 21 claimed sequence;11: PN: JP2011030453 SEQID: 8 unclaimed protein;11: PN: JP2022042061 PAGE: 2 claimed sequence;11: PN: WO2012060351 SEQID: 11 claimed protein;11: PN: WO2012168532 SEQID: 17 claimed protein;12: PN: JP2002320666 SEQID: 12 claimed protein;12: PN: US20200299627 SEQID: 12 claimed protein;12: PN: WO2019113026 SEQID: 12 claimed sequence;12: PN: WO2020079303 SEQID: 17 claimed protein;147: PN: WO2012045822 PAGE: 9 unclaimed sequence;14: PN: WO2011109732 SEQID: 14 claimed protein;14: PN: WO2018022553 SEQID: 14 claimed protein;18: PN: WO2020069429 SEQID: 39 claimed protein;19: PN: WO2011005510 SEQID: 14 unclaimed sequence;1: PN: US6060317 SEQID: 1 unclaimed sequence;1: PN: WO2004108888 SEQID: 2 unclaimed sequence;1: PN: WO2011005510 PAGE: 38 claimed sequence;1: PN: WO2011036326 SEQID: 5 unclaimed protein;20: PN: US20040037775 SEQID: 10 claimed sequence;21: PN: US20020198360 SEQID: 2 unclaimed sequence;21: PN: WO0044808 TABLE: 4 unclaimed sequence;21: PN: WO2013144412 SEQID: 21 unclaimed protein;22: PN: WO2014042463 SEQID: 23 unclaimed protein;24: PN: JP2013176547 SEQID: 24 claimed protein;25: PN: JP2006042794 SEQID: 8 unclaimed protein;262: PN: WO2021146455 SEQID: 335 claimed protein;28: PN: WO2007097251 SEQID: 27 claimed sequence;2: PN: US20140004158 SEQID: 2 claimed sequence;2: PN: WO2009120895 SEQID: 2 claimed sequence;2: PN: WO2021186431 SEQID: 54 claimed sequence;33: PN: US20110200560 SEQID: 33 claimed sequence;34: PN: JP2009072081 SEQID: 8 unclaimed protein;36: PN: DE102008060991 PAGE: 9/20 claimed protein;36: PN: DE102008060992 TABLE: 1 claimed protein;36: PN: JP2005263631 SEQID: 35 unclaimed sequence;38: PN: JP2006174826 SEQID: 8 unclaimed protein;38: PN: JP2013090574 SEQID: 38 unclaimed protein;3: PN: CN101264330 PAGE: 2 claimed protein;3: PN: US20060029544 PAGE: 7 unclaimed sequence;3: PN: WO0166164 PAGE: 30 claimed sequence;3: PN: WO2010099463 SEQID: 7 unclaimed sequence;3: PN: WO2019172358 SEQID: 3 claimed protein;3: PN: WO2022098777 SEQID: 3 claimed protein;40: PN: WO2011090065 SEQID: 38 unclaimed protein;41: PN: US7291673 SEQID: 48 unclaimed sequence;44: PN: US20110311490 SEQID: 2 claimed sequence;49: PN: EP3415165 SEQID: 49 claimed protein;49: PN: WO2005014615 SEQID: 61 unclaimed sequence;4: PN: SG10201703850 PAGE: 27 claimed sequence;4: PN: US20140287507 SEQID: 4 claimed sequence;4: PN: US20180346902 SEQID: 25 claimed protein;4: PN: WO2005027990 SEQID: 4 claimed protein;4: PN: WO2019046943 PAGE: 47 claimed sequence;50: PN: US6958212 SEQID: 48 unclaimed sequence;51: PN: WO2010114143 SEQID: 51 claimed sequence;588: PN: WO0069900 SEQID: 1278 unclaimed sequence;5: PN: JP2013006810 PAGE: 9 unclaimed sequence;61: PN: US20050181973 SEQID: 61 unclaimed sequence;62: PN: US20120014925 SEQID: 62 unclaimed sequence;62: PN: WO2012008967 SEQID: 62 unclaimed sequence;66: PN: WO2007108205 SEQID: 8 unclaimed sequence;6: PN: US6331422 SEQID: 6 claimed protein;7: PN: ES2455441 SEQID: 7 claimed sequence;7: PN: JP2003089648 SEQID: 8 unclaimed;7: PN: WO2004087767 SEQID: 7 claimed sequence;7: PN: WO2005103235 SEQID: 8 unclaimed protein;7: PN: WO2014041231 SEQID: 7 claimed sequence;7: PN: WO2022027020 PAGE: 57 claimed sequence;7: PN: WO2022049154 SEQID: 11 claimed protein;8: PN: JP2002369878 SEQID: 8 claimed protein;8: PN: JP2003189848 SEQID: 8 claimed sequence;8: PN: JP2003210166 SEQID: 8 claimed protein;8: PN: JP2003299481 SEQID: 8 claimed protein;8: PN: JP2005002106 SEQID: 8 claimed sequence;8: PN: JP2006150072 SEQID: 8 claimed protein;8: PN: JP2007051127 SEQID: 8 claimed protein;8: PN: JP2009007339 SEQID: 8 claimed protein;8: PN: JP2010148486 SEQID: 8 unclaimed protein;8: PN: JP2012126707 SEQID: 8 claimed protein;8: PN: JP2018143211 SEQID: 8 claimed protein;9: PN: EP2564880 SEQID: 10 unclaimed protein;9: PN: US20200370021 SEQID: 23 claimed protein;Peptide (mouse protein CHL1 integrin interaction motif)
分子式:C14H22N4O9
分子量:390.35
CAS号:134580-64-6
纯度:
沸点:955.2±65.0 °C | Condition: Press: 760 Torr
密度:1.466±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数:3.36±0.10 | Condition: Most Acidic Temp: 25 °C
储存条件:-20℃,干燥、避光、密封
规格:5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位:四川省维克奇生物科技有限公司
供应电话:028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等,敬请关注! 新批次有现货,欢迎咨询。